Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
3(75.0%)
N/A
1(25.0%)
4Total
Phase 4(3)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06207526Not ApplicableUnknown

Delusion Ideation in the Context of Everyday Life

Role: collaborator

NCT00167843Phase 4Completed

Reducing the Effects of Malaria in Children by Administering Repeated Preventive Doses

Role: collaborator

NCT00206739Phase 4Completed

Intermittent Treatment With Sulfadoxine-pyrimethamine for Malaria Control in Infants

Role: collaborator

NCT00168948Phase 4Unknown

Intermittent Antimalaria Treatment With SP in African Children

Role: collaborator

All 4 trials loaded